Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Identification of Healthy Donor Phenotypic and Functional Signatures That Predict Allogeneic, Hypoimmune CD19-Directed CAR T Cell Potency

Blood (2023) 142 (Supplement 1): 6810.

https://doi.org/10.1182/blood-2023-188264

Published: 2023

Journal Articles

EFA (9-β-D-erythrofuranosyladenine) is an effective salvage agent for methylthioadenosine phosphorylase-selective therapy of T-cell acute lymphoblastic leukemia with L-alanosine

Ayse Batova, Howard Cottam, John Yu, Mitchell B. Diccianni, Carlos J. Carrera, Alice L. Yu

Blood (2006) 107 (3): 898–903.

https://doi.org/10.1182/blood-2005-06-2430

Published: 2006

Journal Articles

A Murine Model of Human Primary Leukemia for Studying Leukemia-Stromal Interactions and Prediction of Clinical Outcome.

John Yu, M.D., Ph.D., Li-en Shao, M.D., Chia-lin Huang, Alice L. Yu, M.D., Ph.D.

Blood (2004) 104 (11): 1192.

https://doi.org/10.1182/blood.V104.11.1192.1192

Published: 2004

Journal Articles

The histone deacetylase inhibitor AN-9 has selective toxicity to acute leukemia and drug-resistant primary leukemia and cancer cell lines

Ayse Batova, Li-en Shao, Mitchell B. Diccianni, Alice L.Yu, Tetsuya Tanaka, Ada Rephaeli, Abraham Nudelman, John Yu

Blood (2002) 100 (9): 3319–3324.

https://doi.org/10.1182/blood-2002-02-0567

Published: 2002

Journal Articles

Preconditioning with fetal cord blood facilitates engraftment of primary childhood T-cell acute lymphoblastic leukemia in immunodeficient mice

Deno P. Dialynas, Mi-Jeong Lee, Daniel P. Gold, Li-en Shao, Alice L. Yu, Michael J. Borowitz, John Yu

Blood (2001) 97 (10): 3218–3225.

https://doi.org/10.1182/blood.V97.10.3218

Published: 2001

NARROW

Identification of Healthy Donor Phenotypic and Functional Signatures That Predict Allogeneic, Hypoimmune CD19-Directed CAR T Cell Potency

EFA (9-β-D-erythrofuranosyladenine) is an effective salvage agent for methylthioadenosine phosphorylase-selective therapy of T-cell acute lymphoblastic leukemia with L-alanosine

A Murine Model of Human Primary Leukemia for Studying Leukemia-Stromal Interactions and Prediction of Clinical Outcome.

The histone deacetylase inhibitor AN-9 has selective toxicity to acute leukemia and drug-resistant primary leukemia and cancer cell lines

Preconditioning with fetal cord blood facilitates engraftment of primary childhood T-cell acute lymphoblastic leukemia in immunodeficient mice

Email alerts

ASH Publications

American Society of Hematology

Identification of Healthy Donor Phenotypic and Functional Signatures That Predict Allogeneic, Hypoimmune CD19-Directed CAR T Cell Potency

EFA (9-β-D-erythrofuranosyladenine) is an effective salvage agent for methylthioadenosine phosphorylase-selective therapy of T-cell acute lymphoblastic leukemia with L-alanosine

A Murine Model of Human Primary Leukemia for Studying Leukemia-Stromal Interactions and Prediction of Clinical Outcome.

The histone deacetylase inhibitor AN-9 has selective toxicity to acute leukemia and drug-resistant primary leukemia and cancer cell lines

Preconditioning with fetal cord blood facilitates engraftment of primary childhood T-cell acute lymphoblastic leukemia in immunodeficient mice

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only